Surgical adjuvant therapy for breast cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D008408:Mastectomy; D009364:Neoplasm Recurrence, Local; D009360:Neoplastic Cells, Circulating; D011446:Prospective Studies
D000970:Antineoplastic Agents